{
 "edition": "20261008-18",
 "language": "zh-Hant",
 "period_start": "2026-10-08T18:00:00+09:00",
 "period_end": "2026-10-08T21:00:00+09:00",
 "page": 4,
 "pages": 4,
 "received_in_period": 321,
 "listed_in_period": 321,
 "description": "這裡一次整合 2 個國家／地區的新聞與公告：台灣 6 個來源 206 條、日本 1 個來源 115 條。每 180 分鐘一期，這期入庫的所有來源、每一條都列出，附原文網址。",
 "countries": [
  {
   "code": "TW",
   "name": "台灣",
   "items": 206,
   "sources": 6
  },
  {
   "code": "JP",
   "name": "日本",
   "items": 115,
   "sources": 1
  }
 ],
 "number_of_items": 21,
 "items": [
  {
   "id": 3264737,
   "anchor": "n3264737",
   "permalink": "https://ainews.idaeo.ai/180m/20261008-18/index-zh-Hant-p4.html#n3264737",
   "title": "憶聲電子9月營收1.04億元 月增37%、年增54% 營運動能回升",
   "title_state": "source",
   "summary": "憶聲電子(3024-TW)公告2026年9月營收達新台幣1.04億元，月增37%、年增54%，顯示營運動能回升。公司結合成立50週年契機，推進「333轉型戰略」並評估AI技術應用，以強化中長期競爭力。",
   "summary_state": "source",
   "facts": [
    {
     "text": "憶聲電子2026年9月自結合併營收為新台幣1.04億元",
     "state": "source",
     "quote": "2026年9月自結合併營收為新台幣1.04億元"
    },
    {
     "text": "憶聲電子9月營收較上月增加37%",
     "state": "source",
     "quote": "較上月增加37%"
    },
    {
     "text": "憶聲電子9月營收較去年同期成長54%",
     "state": "source",
     "quote": "較去年同期成長54%"
    },
    {
     "text": "憶聲電子正推動「333轉型戰略」",
     "state": "source",
     "quote": "公司近年積極推動「333轉型戰略」"
    },
    {
     "text": "憶聲電子於2026年10月成立50週年",
     "state": "source",
     "quote": "適逢今年10月公司成立50週年"
    }
   ],
   "companies": [
    "憶聲電子",
    "憶聲電子(3024-TW)"
   ],
   "published_at": "2026-10-08T17:40:13+09:00",
   "source_type": "cnyes",
   "source_name": "鉅亨網",
   "country": "TW",
   "country_name": "台灣",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.cnyes.com/news/id/6624780",
   "link_level": "source",
   "link_label": "原文",
   "site_url": "https://ainews.idaeo.ai/a/4289095-zh.html",
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3264736,
   "anchor": "n3264736",
   "permalink": "https://ainews.idaeo.ai/180m/20261008-18/index-zh-Hant-p4.html#n3264736",
   "title": "華碩Q3營收2763億元續創歷史新高 部分伺服器專案遞延10月出貨",
   "title_state": "source",
   "summary": "華碩(2357-TW)公布第三季營收2,763億元創歷史新高，年增近四成。儘管部分伺服器專案遞延至10月出貨，但法人看好其轉向高階市場策略及強勁伺服器業務，預期未來營運將持續走強。",
   "summary_state": "source",
   "facts": [
    {
     "text": "華碩9月集團營收為972億元，年增18%、月增約2.36%",
     "state": "source",
     "quote": "華碩9月集團營收972億元，年增18%、月增約2.36%"
    },
    {
     "text": "華碩第三季集團營收2,763億元，年增38%、季增約7.2%",
     "state": "source",
     "quote": "第三季集團營收2,763億元，年增38%、季增約7.2%"
    },
    {
     "text": "華碩今年累計前三季集團營收約7,424億元，年增約38.51%",
     "state": "source",
     "quote": "今年累計前三季集團營收約7,424億元，年增約38.51%"
    },
    {
     "text": "華碩部分伺服器專案配合客戶資料中心建置時程，遞延至10月出貨",
     "state": "source",
     "quote": "目前尚有部分伺服器專案配合客戶資料中心建置時程，遞延至10月出貨"
    },
    {
     "text": "華碩目前策略已轉往高階市場，有望帶動獲利提升",
     "state": "source",
     "quote": "華碩目前策略已轉往高階市場，有望帶動獲利提升"
    }
   ],
   "companies": [
    "華碩",
    "2357-TW"
   ],
   "published_at": "2026-10-08T17:40:13+09:00",
   "source_type": "cnyes",
   "source_name": "鉅亨網",
   "country": "TW",
   "country_name": "台灣",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.cnyes.com/news/id/6624843",
   "link_level": "source",
   "link_label": "原文",
   "site_url": "https://ainews.idaeo.ai/a/4289101-zh.html",
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3264738,
   "anchor": "n3264738",
   "permalink": "https://ainews.idaeo.ai/180m/20261008-18/index-zh-Hant-p4.html#n3264738",
   "title": "自行車廠巨大9月營收53.68億元年增3% 累計營收衰退收歛",
   "title_state": "source",
   "summary": "巨大集團公布2026年9月營收53.68億元，年增2.88%，累計衰退幅度縮小。中國大陸市場表現強勁，但美國與代工業務受地緣政治及訂單因素影響下滑。",
   "summary_state": "source",
   "facts": [
    {
     "text": "巨大集團2026年9月營收為53.68億元，年成長2.88%。",
     "state": "source",
     "quote": "2026年9月營收53.68億元，月增3.51%，年成長 2.88%"
    },
    {
     "text": "巨大集團2026年1-9月累計營收年減幅度收斂至5.13%。",
     "state": "source",
     "quote": "2026年1-9月累計營收454.99億元，年減幅度持續收斂至 5.13%"
    },
    {
     "text": "巨大集團9月在中國大陸市場因登山車和電動車暢旺，單月營收成長26%。",
     "state": "source",
     "quote": "在中國大陸市場，登山車和電動車銷售暢旺，轉換台幣後，帶動單月營收成長26%"
    },
    {
     "text": "巨大集團9月美國市場營收持續衰退，受WRO事件及伊朗戰爭影響。",
     "state": "source",
     "quote": "美國市場持續受到 WRO 事件影響，及伊朗戰爭影響消費者信心，單月營收仍呈現衰退"
    },
    {
     "text": "巨大集團9月代工業務營收微幅減少，主因是WRO問題及客戶訂單減少。",
     "state": "source",
     "quote": "而巨大9月在代工（OE）業務方面，單月營收表現較去年同期微幅減少，主要歸因於WRO問題的影響以及客戶訂單減少"
    }
   ],
   "companies": [
    "巨大",
    "巨大(9921-TW)"
   ],
   "published_at": "2026-10-08T17:32:23+09:00",
   "source_type": "cnyes",
   "source_name": "鉅亨網",
   "country": "TW",
   "country_name": "台灣",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.cnyes.com/news/id/6624847",
   "link_level": "source",
   "link_label": "原文",
   "site_url": "https://ainews.idaeo.ai/a/4289102-zh.html",
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3264739,
   "anchor": "n3264739",
   "permalink": "https://ainews.idaeo.ai/180m/20261008-18/index-zh-Hant-p4.html#n3264739",
   "title": "光寶科9月營收188億元年增逾2成 AI伺服器電源系統出貨暢旺",
   "title_state": "source",
   "summary": "電源供應廠光寶科(2301-TW)公布9月營收188億元，年增22%，受惠AI伺服器電源、BBU等電能管理系統需求強勁；第三季營收573.98億元，年增27.9%，累計前三季達1,536億元，年增26%。",
   "summary_state": "source",
   "facts": [
    {
     "text": "光寶科9月營收188億元，年增22%。",
     "state": "source",
     "quote": "光寶科9月營收188億元，月減約4%，年增22%"
    },
    {
     "text": "光寶科第三季營收573.98億元，年增約27.9%。",
     "state": "source",
     "quote": "第三季營收573.98億元，季增約8.9%、年增約27.9%"
    },
    {
     "text": "光寶科今年累計前三季營收1,536億元，年增26%。",
     "state": "source",
     "quote": "今年累計前三季營收1,536億元，年增26%"
    },
    {
     "text": "雲端及物聯網部門9月營收佔比達59%，年增逾五成。",
     "state": "source",
     "quote": "雲端及物聯網部門九月份營收佔比達59%；其中，AI、雲端運算及高階伺服器、網通等電能管理系統出貨暢旺，帶動雲端及物聯網部門營收年增逾五成"
    },
    {
     "text": "光電部門9月營收佔整體14%，年成長達一成。",
     "state": "source",
     "quote": "光電部門營收佔整體之14%；其中，高階光耦合器於工控、新能源與AI伺服器電能管理系統需求成長；以及高階可見光受惠於高集成、微型化指示燈應用於 AI 伺服器與交換器之需求穩定成長，共同推升光電部門年成長達一成"
    },
    {
     "text": "資訊及消費性電子部門9月營收佔整體之27%，受惠低軌衛星與高階電源需求穩定成長。",
     "state": "source",
     "quote": "資訊及消費性電子部門營收佔整體之27%；受惠應用市場多元化，低軌衛星與高階電源需求穩定成長"
    }
   ],
   "companies": [
    "光寶科"
   ],
   "published_at": "2026-10-08T17:31:06+09:00",
   "source_type": "cnyes",
   "source_name": "鉅亨網",
   "country": "TW",
   "country_name": "台灣",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.cnyes.com/news/id/6624856",
   "link_level": "source",
   "link_label": "原文",
   "site_url": "https://ainews.idaeo.ai/a/4289103-zh.html",
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3264740,
   "anchor": "n3264740",
   "permalink": "https://ainews.idaeo.ai/180m/20261008-18/index-zh-Hant-p4.html#n3264740",
   "title": "〈陸股盤後〉CPO族群、半導體類股領跌 滬指終止連2紅",
   "title_state": "source",
   "summary": "中國A股三大指數今(8)日長假後向下補跌，創業板領跌，滬指終止連2紅，半導體、CPO族群領跌，石油石化、銀行、固態電池、航運類股逆勢上漲。",
   "summary_state": "source",
   "facts": [
    {
     "text": "上證指數收低0.79%至3811.9點，終止連2個交易日走漲氣勢",
     "state": "source",
     "quote": "上證指數(SSEC)亦結束連2個交易日走漲氣勢"
    },
    {
     "text": "創業板指收跌3.15%至3036.66點，科創50指數收黑4.82%至1456.32點",
     "state": "source",
     "quote": "創業板指收跌3.15%至3036.66點，科創50指數收黑4.82%至1456.32點"
    },
    {
     "text": "滬深兩市成交額人民幣1.68兆元，較上一交易日放量2441億元",
     "state": "source",
     "quote": "滬深兩市成交額人民幣1.68兆元，較上一交易日放量2441億元"
    },
    {
     "text": "半導體、CPO等AI硬體股領跌，源傑科技、長光華芯、東山精密、沃格光電、均勝電子等股跌停",
     "state": "source",
     "quote": "半導體、CPO等AI硬體股表現不佳……源傑科技、長光華芯、東山精密、沃格光電、均勝電子等股跌停"
    },
    {
     "text": "DRAM龍頭長鑫科技盤中跌超8%",
     "state": "source",
     "quote": "DRAM龍頭長鑫科技盤中跌超8%"
    },
    {
     "text": "中國銀行、工商銀行、杭州銀行日內創歷史新高",
     "state": "source",
     "quote": "中國銀行、工商銀行、杭州銀行日內創歷史新高"
    },
    {
     "text": "中遠海能、招商南油漲停",
     "state": "source",
     "quote": "航運類股亦表現佳，中遠海能、招商南油漲停"
    },
    {
     "text": "阿里巴巴、智譜分別完成約800億港元、50億美元融資",
     "state": "source",
     "quote": "阿里巴巴、智譜分別完成約800億港元、50億美元融資"
    }
   ],
   "companies": [
    "源傑科技",
    "長光華芯",
    "東山精密",
    "沃格光電",
    "均勝電子",
    "天孚通訊",
    "長鑫科技",
    "思瑞浦",
    "微導奈米",
    "聖邦股份",
    "博邁科",
    "通源石油",
    "國新能源",
    "廣西能源",
    "中國銀行",
    "工商銀行",
    "杭州銀行",
    "力王股份",
    "雄韜股份",
    "豐元股份",
    "領湃科技",
    "傳藝科技",
    "紫竹高科",
    "中遠海能",
    "招商南油",
    "華泰證券",
    "長江證券",
    "中信建投",
    "阿里巴巴",
    "智譜",
    "騰訊",
    "OpenAI",
    "Anthropic"
   ],
   "published_at": "2026-10-08T17:30:02+09:00",
   "source_type": "cnyes",
   "source_name": "鉅亨網",
   "country": "TW",
   "country_name": "台灣",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.cnyes.com/news/id/6624762",
   "link_level": "source",
   "link_label": "原文",
   "site_url": "https://ainews.idaeo.ai/a/4289097-zh.html",
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3264741,
   "anchor": "n3264741",
   "permalink": "https://ainews.idaeo.ai/180m/20261008-18/index-zh-Hant-p4.html#n3264741",
   "title": "〈電子五哥營收〉緯創AI伺服器帶動營運逐季增 Q3營收衝1.15兆元創歷史單季新高",
   "title_state": "source",
   "summary": "緯創公告9月營收年增逾8成，受惠AI伺服器需求強勁，第三季營收創1.15兆元歷史新高，累計前三季營收亦大幅增長。",
   "summary_state": "source",
   "facts": [
    {
     "text": "緯創第三季營收達1.15兆元，創歷史單季新高。",
     "state": "source",
     "quote": "第三季營收再度站上兆元關卡，達1.15兆元，年增逾1倍，創下歷史單季新高紀錄。"
    },
    {
     "text": "緯創9月營收為3,808.06億元，年增87.19%。",
     "state": "source",
     "quote": "緯創9月營收3808.06億元，月減17.22%，年增87.19%"
    },
    {
     "text": "緯創AI伺服器為公司主要成長引擎，第四季營運將迎來高峰。",
     "state": "source",
     "quote": "AI伺服器仍為公司主要成長引擎，推升今年營運呈現逐季向上，並在第四季迎來高峰。"
    },
    {
     "text": "緯創9月筆電出貨150萬台，年減31.82%。",
     "state": "source",
     "quote": "緯創9月筆電出貨150萬台，月增7.14%，年減31.82%"
    },
    {
     "text": "緯創累計今年前三季營收2.89兆元，年增97.25%。",
     "state": "source",
     "quote": "累計今年前三季營收2.89兆元，年增97.25%，同步改寫歷史同期高。"
    }
   ],
   "companies": [
    "緯創"
   ],
   "published_at": "2026-10-08T17:29:46+09:00",
   "source_type": "cnyes",
   "source_name": "鉅亨網",
   "country": "TW",
   "country_name": "台灣",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.cnyes.com/news/id/6624855",
   "link_level": "source",
   "link_label": "原文",
   "site_url": "https://ainews.idaeo.ai/a/4289104-zh.html",
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3264742,
   "anchor": "n3264742",
   "permalink": "https://ainews.idaeo.ai/180m/20261008-18/index-zh-Hant-p4.html#n3264742",
   "title": "川普政府再收緊簽證！國際生留美工作 擬收7萬美元實習費",
   "title_state": "source",
   "summary": "美國國土安全部提議大幅提高國際學生OPT實習費用至7萬美元，作為川普政府收緊簽證政策的一部分，旨在保護美國勞工並打擊詐欺，但該提案預計將面臨法律挑戰。",
   "summary_state": "source",
   "facts": [
    {
     "text": "美國國土安全部提議國際學生參加OPT須支付至少7萬美元實習費",
     "state": "source",
     "quote": "根據提案，持F-1非移民學生簽證的外籍學生，須向認證機構支付7萬美元，才能參加稱為「選擇性實習訓練」（Optional Practical Training，OPT）的在職訓練"
    },
    {
     "text": "參與額外工作訓練還須支付3萬美元",
     "state": "source",
     "quote": "若要接受額外工作訓練，還須支付3萬美元"
    },
    {
     "text": "目前參加OPT者須支付的費用約為500美元",
     "state": "source",
     "quote": "目前參加者須支付的費用約為500美元"
    },
    {
     "text": "新規旨在打擊詐欺、強化移民制度健全性並保護美國勞工",
     "state": "source",
     "quote": "國土安全部表示，新規旨在「打擊詐欺、強化移民制度的健全性，並保護美國勞工」"
    },
    {
     "text": "提案須經過30天公眾意見徵詢期，定案後再等60天實施",
     "state": "source",
     "quote": "這項提案須先經過30天的公眾意見徵詢期，才能定案。國土安全部表示，規則定案後將再等60天才實施"
    }
   ],
   "companies": [],
   "published_at": "2026-10-08T17:20:02+09:00",
   "source_type": "cnyes",
   "source_name": "鉅亨網",
   "country": "TW",
   "country_name": "台灣",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.cnyes.com/news/id/6624803",
   "link_level": "source",
   "link_label": "原文",
   "site_url": "https://ainews.idaeo.ai/a/4289099-zh.html",
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3264743,
   "anchor": "n3264743",
   "permalink": "https://ainews.idaeo.ai/180m/20261008-18/index-zh-Hant-p4.html#n3264743",
   "title": "中歐貿易談判在北京展開 歐盟對逆差問題採取更強硬立場",
   "title_state": "source",
   "summary": "歐盟與中國將於北京展開貿易談判，聚焦於每日逾10億歐元逆差及稀土管制問題。歐盟內部強硬派主張建立「可信工具」以應對潛在貿易衝突，中方則嚴正警告反對保護主義並誓言反制。",
   "summary_state": "source",
   "facts": [
    {
     "text": "歐盟與中國即將於北京展開為期兩天的貿易談判。",
     "state": "source",
     "quote": "歐盟與中國即將於北京展開為期兩天的貿易談判"
    },
    {
     "text": "歐盟貿易事務委員謝夫喬維奇已抵達北京，將與中國商務部長王文濤進行談判。",
     "state": "source",
     "quote": "歐盟貿易事務委員謝夫喬維奇(Maros Sefcovic)已抵達北京，本周將與中國商務部長王文濤展開為期兩天的貿易談判"
    },
    {
     "text": "歐盟面臨每日高達逾10億歐元的巨額貿易逆差。",
     "state": "source",
     "quote": "本次會談的核心在於化解歐盟每天高達逾10億歐元的巨額貿易逆差"
    },
    {
     "text": "法國總統馬克宏與德國總理梅爾茨聯合提議建立具威懾力的「可信工具」。",
     "state": "source",
     "quote": "法國總統馬克宏(Emmanuel Macron)與德國總理梅爾茨(Friedrich Merz)聯合向歐盟提議，應建立一套具威懾力的「可信工具」"
    },
    {
     "text": "歐盟執委會準備對中國油電混合動力車實施關稅配額等防衛限制措施。",
     "state": "source",
     "quote": "歐盟執委會正準備對中國油電混合動力車實施關稅配額等防衛限制措施"
    },
    {
     "text": "中國商務部警告法德兩國切勿轉向保護主義。",
     "state": "source",
     "quote": "中國商務部要求法德兩國切勿轉向「保護主義」"
    }
   ],
   "companies": [],
   "published_at": "2026-10-08T17:10:04+09:00",
   "source_type": "cnyes",
   "source_name": "鉅亨網",
   "country": "TW",
   "country_name": "台灣",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.cnyes.com/news/id/6624770",
   "link_level": "source",
   "link_label": "原文",
   "site_url": "https://ainews.idaeo.ai/a/4289105-zh.html",
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3265132,
   "anchor": "n3265132",
   "permalink": "https://ainews.idaeo.ai/180m/20261008-18/index-zh-Hant-p4.html#n3265132",
   "title": "台股一周TOP 15：10/02-10/08(漲)浩鼎27.86%、瑞基21.41%、泰福-KY14.7%-環球生技月刊",
   "title_state": "source",
   "summary": "2026年10月2日至8日台股上市櫃近一周漲幅TOP 15排行，浩鼎以27.86%居首，瑞基與泰福-KY分別為21.41%及14.70%，並列出近一月漲幅排行。",
   "summary_state": "source",
   "facts": [],
   "companies": [
    "浩鼎",
    "瑞基",
    "泰福-KY",
    "松瑞藥",
    "亞諾法",
    "益得",
    "合世",
    "永笙-KY",
    "太景*-KY",
    "馬光-KY",
    "國光生",
    "華安",
    "南光",
    "豪展",
    "金萬林-創",
    "睿生光電",
    "禾榮科",
    "圓祥生技",
    "全福生技",
    "漢達",
    "基米-創",
    "浩宇生醫",
    "漢康-KY創",
    "基亞"
   ],
   "published_at": "2026-10-08T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "台灣",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=90623&kind=20",
   "link_level": "source",
   "link_label": "原文",
   "site_url": "https://ainews.idaeo.ai/a/4289854-zh.html",
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3265131,
   "anchor": "n3265131",
   "permalink": "https://ainews.idaeo.ai/180m/20261008-18/index-zh-Hant-p4.html#n3265131",
   "title": "法人一周動態：10/02-10/08(買超)松瑞藥3776張、國光生1978張、東洋1243張；(賣超)康霈*2450張、浩鼎1449張、漢達913張-環球生技月刊",
   "title_state": "source",
   "summary": "2026年10月2日至8日三大法人買賣超動態，松瑞藥、國光生、東洋為買超前三大；康霈、浩鼎、漢達為賣超前三大。",
   "summary_state": "source",
   "facts": [],
   "companies": [
    "松瑞藥",
    "國光生",
    "東洋",
    "康霈",
    "浩鼎",
    "漢達",
    "中天",
    "大江",
    "健喬",
    "沛爾生醫*-創",
    "晟德",
    "國邑*",
    "晶碩",
    "台耀",
    "藥華藥",
    "視陽",
    "泰博",
    "保瑞",
    "麗豐-KY",
    "禾榮科"
   ],
   "published_at": "2026-10-08T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "台灣",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=90624&kind=20",
   "link_level": "source",
   "link_label": "原文",
   "site_url": "https://ainews.idaeo.ai/a/4289856-zh.html",
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3265130,
   "anchor": "n3265130",
   "permalink": "https://ainews.idaeo.ai/180m/20261008-18/index-zh-Hant-p4.html#n3265130",
   "title": "盤點10/02-10/08興櫃人氣股－仁新*、安成生技、樂迦再生；漲幅王－鼎晉生技、寶泰生醫、安成生技-環球生技月刊",
   "title_state": "source",
   "summary": "盤點10/02-10/08興櫃市場人氣股與漲幅王，仁新*、安成生技、樂迦再生為成交熱門標的，鼎晉生技以62.49%漲幅居冠。",
   "summary_state": "source",
   "facts": [
    {
     "text": "62.49%",
     "state": "source",
     "quote": "62.49%"
    },
    {
     "text": "24.85%",
     "state": "source",
     "quote": "24.85%"
    },
    {
     "text": "20.92%",
     "state": "source",
     "quote": "20.92%"
    }
   ],
   "companies": [
    "仁新*",
    "安成生技",
    "樂迦再生",
    "鼎晉生技",
    "寶泰生醫",
    "仲恩生醫",
    "安基生技",
    "安立璽榮-KY",
    "瀚陽*",
    "水星生醫*",
    "新穎生醫",
    "禾生技",
    "視航生醫",
    "宣捷幹細胞",
    "大江基因"
   ],
   "published_at": "2026-10-08T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "台灣",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=90625&kind=20",
   "link_level": "source",
   "link_label": "原文",
   "site_url": "https://ainews.idaeo.ai/a/4289851-zh.html",
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3265129,
   "anchor": "n3265129",
   "permalink": "https://ainews.idaeo.ai/180m/20261008-18/index-zh-Hant-p4.html#n3265129",
   "title": "10/02-10/08生技股週報快訊：鼎晉生技漲幅62.49%、浩鼎漲27.86%奪冠-環球生技月刊",
   "title_state": "source",
   "summary": "10/02-10/08生技股週報快訊：鼎晉生技漲幅62.49%、浩鼎漲27.86%奪冠",
   "summary_state": "source",
   "facts": [
    {
     "text": "瑞基(4171)➡️週漲21.41%",
     "state": "source",
     "quote": "瑞基(4171)➡️週漲21.41%"
    },
    {
     "text": "泰福-KY(6541)➡️週漲14.7%",
     "state": "source",
     "quote": "泰福-KY(6541)➡️週漲14.7%"
    },
    {
     "text": "松瑞藥(4167)：3776張",
     "state": "source",
     "quote": "松瑞藥(4167)：3776張"
    },
    {
     "text": "國光生(4142)：1978張",
     "state": "source",
     "quote": "國光生(4142)：1978張"
    },
    {
     "text": "東洋(4105)：1243張",
     "state": "source",
     "quote": "東洋(4105)：1243張"
    },
    {
     "text": "寶泰生醫(7850)➡️週漲24.85%",
     "state": "source",
     "quote": "寶泰生醫(7850)➡️週漲24.85%"
    },
    {
     "text": "安成生技(6610)➡️週漲20.92%",
     "state": "source",
     "quote": "安成生技(6610)➡️週漲20.92%"
    },
    {
     "text": "仁新*(6696)：33883張",
     "state": "source",
     "quote": "仁新*(6696)：33883張"
    },
    {
     "text": "安成生技(6610)：18706張",
     "state": "source",
     "quote": "安成生技(6610)：18706張"
    },
    {
     "text": "樂迦再生(6891)：13901張",
     "state": "source",
     "quote": "樂迦再生(6891)：13901張"
    }
   ],
   "companies": [
    "鼎晉生技",
    "浩鼎",
    "瑞基",
    "泰福-KY",
    "松瑞藥",
    "國光生",
    "東洋",
    "寶泰生醫",
    "安成生技",
    "仁新*",
    "樂迦再生",
    "睿生光電",
    "禾榮科",
    "圓祥生技",
    "全福生技",
    "漢達",
    "基米-創",
    "浩宇生醫",
    "亞諾法",
    "益得",
    "合世",
    "永笙-KY",
    "太景*-KY"
   ],
   "published_at": "2026-10-08T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "台灣",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=90626&kind=20",
   "link_level": "source",
   "link_label": "原文",
   "site_url": "https://ainews.idaeo.ai/a/4289852-zh.html",
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3265128,
   "anchor": "n3265128",
   "permalink": "https://ainews.idaeo.ai/180m/20261008-18/index-zh-Hant-p4.html#n3265128",
   "title": "10/08《生技股動態》-環球生技月刊",
   "title_state": "source",
   "summary": "10/08生技股動態涵蓋三福化、聯亞藥、心誠鎂、原創生醫及泰合生技等公司之授權、合約與發行情況，並列出當日漲跌個股及法人買賣超動向。",
   "summary_state": "source",
   "facts": [
    {
     "text": "初上市前現增750萬股案",
     "state": "source",
     "quote": "初上市前現增750萬股案"
    },
    {
     "text": "承銷價105.6元",
     "state": "source",
     "quote": "承銷價105.6元"
    },
    {
     "text": "合世9.77%",
     "state": "source",
     "quote": "合世9.77%"
    },
    {
     "text": "金萬林-創9.76%",
     "state": "source",
     "quote": "金萬林-創9.76%"
    },
    {
     "text": "太景*-KY9.12%",
     "state": "source",
     "quote": "太景*-KY9.12%"
    },
    {
     "text": "天良5.48%",
     "state": "source",
     "quote": "天良5.48%"
    },
    {
     "text": "圓祥生技5%",
     "state": "source",
     "quote": "圓祥生技5%"
    },
    {
     "text": "台聯電4.09%",
     "state": "source",
     "quote": "台聯電4.09%"
    },
    {
     "text": "松瑞藥2298張",
     "state": "source",
     "quote": "松瑞藥2298張"
    },
    {
     "text": "健喬1304張",
     "state": "source",
     "quote": "健喬1304張"
    },
    {
     "text": "中天570張",
     "state": "source",
     "quote": "中天570張"
    },
    {
     "text": "康霈*961張",
     "state": "source",
     "quote": "康霈*961張"
    },
    {
     "text": "全福生技282張",
     "state": "source",
     "quote": "全福生技282張"
    },
    {
     "text": "漢達242張",
     "state": "source",
     "quote": "漢達242張"
    }
   ],
   "companies": [
    "三福化",
    "三福生醫",
    "Ainos",
    "聯亞藥",
    "生技中心",
    "心誠鎂",
    "原創生醫",
    "泰合生技",
    "合世",
    "金萬林-創",
    "太景*-KY",
    "天良",
    "圓祥生技",
    "台聯電",
    "松瑞藥",
    "健喬",
    "中天",
    "康霈*",
    "全福生技",
    "漢達"
   ],
   "published_at": "2026-10-08T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "台灣",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=90640&kind=20",
   "link_level": "source",
   "link_label": "原文",
   "site_url": "https://ainews.idaeo.ai/a/4289849-zh.html",
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3265127,
   "anchor": "n3265127",
   "permalink": "https://ainews.idaeo.ai/180m/20261008-18/index-zh-Hant-p4.html#n3265127",
   "title": "泰合生技(6467)初上市前現增750萬股案，承銷價105.6元-環球生技月刊",
   "title_state": "source",
   "summary": "泰合生技(6467)公告初次上市前現金增資發行新股承銷價格為每股新台幣105.6元，共發行750萬股。",
   "summary_state": "source",
   "facts": [
    {
     "text": "發行普通股7,500,000股",
     "state": "source",
     "quote": "發行普通股7,500,000股"
    },
    {
     "text": "每股新台幣105.6元",
     "state": "source",
     "quote": "每股新台幣105.6元"
    },
    {
     "text": "最低承銷價格為每股新台幣88元",
     "state": "source",
     "quote": "最低承銷價格為每股新台幣88元"
    },
    {
     "text": "加權平均價格為新台幣177.88元",
     "state": "source",
     "quote": "加權平均價格為新台幣177.88元"
    }
   ],
   "companies": [
    "泰合生技股份有限公司",
    "泰合生技",
    "臺灣證券交易所股份有限公司"
   ],
   "published_at": "2026-10-08T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "台灣",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=90635&kind=21",
   "link_level": "source",
   "link_label": "原文",
   "site_url": "https://ainews.idaeo.ai/a/4289859-zh.html",
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3265126,
   "anchor": "n3265126",
   "permalink": "https://ainews.idaeo.ai/180m/20261008-18/index-zh-Hant-p4.html#n3265126",
   "title": "元勛(7660)財會主管謝元勝辭任-環球生技月刊",
   "title_state": "source",
   "summary": "元勛(7660)公告財會主管謝元勝因個人生涯規劃辭任，生效日為115/10/08，新任人選待董事會決議後公告。",
   "summary_state": "source",
   "facts": [
    {
     "text": "115/10/08",
     "state": "source",
     "quote": "115/10/08"
    }
   ],
   "companies": [
    "元勛"
   ],
   "published_at": "2026-10-08T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "台灣",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=90636&kind=21",
   "link_level": "source",
   "link_label": "原文",
   "site_url": "https://ainews.idaeo.ai/a/4289855-zh.html",
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3265125,
   "anchor": "n3265125",
   "permalink": "https://ainews.idaeo.ai/180m/20261008-18/index-zh-Hant-p4.html#n3265125",
   "title": "台寶生醫(6892)更正115/06/09法說會簡報資訊部分內容-環球生技月刊",
   "title_state": "source",
   "summary": "台寶生醫(6892)更正115/06/09法說會簡報資訊，刪除關於以台灣為製造基地及PIC/S GMP等級廠之描述。公司說明竹北細胞生產工廠雖依PIC/S GMP規格建置且曾獲TFDA先導工廠評鑑，但現正評估導入FAST CGT平台新製程，暫不申請GMP展延，本次更正未影響財務業務資訊。",
   "summary_state": "source",
   "facts": [
    {
     "text": "115/06/09法說會",
     "state": "source",
     "quote": "115/06/09法說會"
    },
    {
     "text": "事實發生日:115/10/08",
     "state": "source",
     "quote": "事實發生日:115/10/08"
    },
    {
     "text": "第13頁",
     "state": "source",
     "quote": "第13頁"
    },
    {
     "text": "民國113年5月22日",
     "state": "source",
     "quote": "民國113年5月22日"
    },
    {
     "text": "民國115年5月22日",
     "state": "source",
     "quote": "民國115年5月22日"
    }
   ],
   "companies": [
    "台寶生醫股份有限公司",
    "TFDA"
   ],
   "published_at": "2026-10-08T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "台灣",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=90637&kind=21",
   "link_level": "source",
   "link_label": "原文",
   "site_url": "https://ainews.idaeo.ai/a/4289853-zh.html",
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3265124,
   "anchor": "n3265124",
   "permalink": "https://ainews.idaeo.ai/180m/20261008-18/index-zh-Hant-p4.html#n3265124",
   "title": "奧孟亞(7776)10/14受邀參加凱基證券舉辦之法人說明會-環球生技月刊",
   "title_state": "source",
   "summary": "奧孟亞(7776)於10月14日受邀參加凱基證券舉辦之法人說明會，說明研發進程、商務開發成果及市場展望。",
   "summary_state": "source",
   "facts": [
    {
     "text": "7776",
     "state": "source",
     "quote": "7776"
    },
    {
     "text": "10/14",
     "state": "source",
     "quote": "10/14"
    },
    {
     "text": "14 時 00 分",
     "state": "source",
     "quote": "14 時 00 分"
    }
   ],
   "companies": [
    "奧孟亞",
    "凱基證券"
   ],
   "published_at": "2026-10-08T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "台灣",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=90638&kind=21",
   "link_level": "source",
   "link_label": "原文",
   "site_url": "https://ainews.idaeo.ai/a/4289857-zh.html",
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3265123,
   "anchor": "n3265123",
   "permalink": "https://ainews.idaeo.ai/180m/20261008-18/index-zh-Hant-p4.html#n3265123",
   "title": "岱宇(1598)10/13受邀參加寬量國際主辦之「20th QIC CEO Week」-環球生技月刊",
   "title_state": "source",
   "summary": "岱宇(1598)於10/13受邀參加寬量國際主辦之「20th QIC CEO Week」，向投資人說明營運概況、財務及業務資訊。",
   "summary_state": "source",
   "facts": [
    {
     "text": "10/13",
     "state": "source",
     "quote": "10/13"
    },
    {
     "text": "20th QIC CEO Week",
     "state": "source",
     "quote": "20th QIC CEO Week"
    }
   ],
   "companies": [
    "岱宇",
    "寬量國際"
   ],
   "published_at": "2026-10-08T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "台灣",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=90639&kind=21",
   "link_level": "source",
   "link_label": "原文",
   "site_url": "https://ainews.idaeo.ai/a/4289858-zh.html",
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3265117,
   "anchor": "n3265117",
   "permalink": "https://ainews.idaeo.ai/180m/20261008-18/index-zh-Hant-p4.html#n3265117",
   "title": "10/08《生技股動態》-環球生技月刊",
   "title_state": "source",
   "summary": "10/8生技股動態：三福化與Ainos簽低劑量口服干擾素全球授權合約；聯亞藥終止抗癌藥UB-941技術授權；心誠鎂簽署國際製藥主服務合約；原創生醫取得歐洲發明專利；泰合生技初上市前現增750萬股。",
   "summary_state": "source",
   "facts": [
    {
     "text": "現增750萬股案",
     "state": "source",
     "quote": "現增750萬股案"
    },
    {
     "text": "承銷價105.6元",
     "state": "source",
     "quote": "承銷價105.6元"
    }
   ],
   "companies": [
    "三福化",
    "三福生醫",
    "Ainos",
    "聯亞藥",
    "生技中心",
    "心誠鎂",
    "原創生醫",
    "泰合生技",
    "合世",
    "金萬林-創",
    "太景*-KY",
    "天良",
    "圓祥生技",
    "台聯電",
    "松瑞藥",
    "健喬",
    "中天",
    "康霈*",
    "全福生技",
    "漢達"
   ],
   "published_at": "2026-10-08T01:00:00+09:00",
   "source_type": "gbimonthly",
   "source_name": "環球生技月刊",
   "country": "TW",
   "country_name": "台灣",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://news.gbimonthly.com/tw/invest/show.php?num=90640&range=news",
   "link_level": "source",
   "link_label": "原文",
   "site_url": "https://ainews.idaeo.ai/a/4289861-zh.html",
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3265169,
   "anchor": "n3265169",
   "permalink": "https://ainews.idaeo.ai/180m/20261008-18/index-zh-Hant-p4.html#n3265169",
   "title": "產前檢查發現胎兒唇顎裂怎麼辦？醫籲：家長掌握「這」原則，給孩子一個機會 - Heho健康",
   "title_state": "source",
   "summary": "台灣每100個胎兒中約4個有異常，包含唇顎裂等問題；過往準父母常因擔憂治療、照顧及未來歧視而焦慮或選擇終止妊娠。",
   "summary_state": "source",
   "facts": [
    {
     "text": "每 100 個胎兒",
     "state": "source",
     "quote": "每 100 個胎兒"
    },
    {
     "text": "約 4 個",
     "state": "source",
     "quote": "約 4 個"
    }
   ],
   "companies": [],
   "published_at": "2026-10-08T19:10:19+09:00",
   "source_type": "heho",
   "source_name": "Heho健康",
   "country": "TW",
   "country_name": "台灣",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://heho.com.tw/archives/388010",
   "link_level": "source",
   "link_label": "原文",
   "site_url": "https://ainews.idaeo.ai/a/4289883-zh.html",
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  },
  {
   "id": 3265237,
   "anchor": "n3265237",
   "permalink": "https://ainews.idaeo.ai/180m/20261008-18/index-zh-Hant-p4.html#n3265237",
   "title": "【會務快報】感謝卓榮泰院長、石崇良部長及陳亮妤署長，額外預算挹注2.5億元獎勵連假開診；本會籲依醫療",
   "title_state": "source",
   "summary": "中華民國醫師公會全國聯合會感謝行政院、衛福部及健保署額外挹注2.5億元預算，推動國定連假醫療加成獎勵政策，以支持院所因應民眾需求開診並分流急診負荷。",
   "summary_state": "source",
   "facts": [
    {
     "text": "2.5億元",
     "state": "source",
     "quote": "2.5億元"
    },
    {
     "text": "加成 50%",
     "state": "source",
     "quote": "加成 50%"
    }
   ],
   "companies": [
    "中華民國醫師公會全國聯合會",
    "衛福部",
    "行政院",
    "健保署"
   ],
   "published_at": "2026-10-08T01:00:00+09:00",
   "source_type": "tma",
   "source_name": "中華民國醫師公會全國聯合會",
   "country": "TW",
   "country_name": "台灣",
   "source_language": "zh-TW",
   "summary_language": "zh-TW",
   "url": "https://www.tma.tw/meeting/meeting_info.asp?/14806.html",
   "link_level": "source",
   "link_label": "原文",
   "site_url": "https://ainews.idaeo.ai/a/4289927-zh.html",
   "merged_count": 1,
   "merged_ids": [],
   "merged_urls": []
  }
 ]
}